| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$116 |
HREC Approval Accelerates Global Phase 3 DFI Strategy
|
22 Jun 2026 10:03AM |
$0.485 |
$0.380 |
fallen by
21.65%
|
|
RCE - Price-sensitive ASX Announcement
Full Release
Key Points
- HREC approval received for Phase 3 trial of RECCE® 327 Topical Gel in Australia.
- The trial expands patient eligibility to include Moderate DFI, broadening recruitment.
- Study includes infected ulcers below the knee for additional endpoint analysis.
- Two concurrent Phase 3 trials in Australia and Indonesia to US FDA standards.
- Expected full enrolment by end of 2027, with interim analysis at 50% completion.
- Previous Phase II trials showed 93% efficacy at Day 14 with no serious adverse events.
- Recce’s global strategy targets approvals in Australia, US, MENA, and ASEAN markets.
- The company has a non-binding term sheet with a Middle Eastern pharmaceutical company.
- Recce Pharmaceuticals develops new synthetic anti-infectives for antibiotic-resistant bacteria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$588 |
Notification of cessation of securities - SHV
|
22 Jun 2026 9:57AM |
$4.010 |
$4.160 |
risen by
3.74%
|
|
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,683 |
Dividend/Distribution - GLF
|
22 Jun 2026 9:53AM |
$4.750 |
$4.425 |
fallen by
6.84%
|
|
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$449 |
Notification of cessation of securities - EOL
|
22 Jun 2026 9:52AM |
$12.210 |
$14.130 |
risen by
15.72%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,188 |
Supp. Target Statement - asset sale and distribution update
|
22 Jun 2026 9:50AM |
$5.100 |
$4.945 |
fallen by
3.04%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria recommends rejecting the IFM takeover offer.
- Offer is undervalued compared to the Independent Expert's valuation.
- ALX targets 60.0 cents distribution per security for the next year.
- Potential sale of Warnow Tunnel to Eiffage S.A. is under negotiation.
- Sale proceeds must first cover the Bridge Facility before extra distributions.
- Market participants may consider restricting stock lending of ALX Securities.
- Fifth Supplementary Target’s Statement lodged with ASIC on June 22, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Minbos Resources Limited (MNB) ORDINARY FULLY PAID |
Materials |
$23 |
Pause in Trading
|
22 Jun 2026 9:49AM |
$0.020 |
$0.018 |
fallen by
12.50%
|
|
MNB - Price-sensitive ASX Announcement
Full Release
Key Points
- Minbos Resources Limited is the company involved.
- Security Code for Minbos is MNB.
- There is a pause in trading of Minbos securities.
- The trading pause is temporary.
- Awaiting further announcement for more information.
- Action complies with ASX listings requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$100 |
Suspension from Quotation
|
22 Jun 2026 9:48AM |
$0.660 |
$0.233 |
fallen by
64.77%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Lotus Resources Limited (ASX: LOT) requested a suspension from quotation.
- Suspension is due to the inability to make an announcement regarding the Kayelekera Project.
- Key issues include delayed acid supply and damage to the acid plant.
- Suspension will last until 25 June 2026 or until the necessary announcements are made.
- Lotus Resources aims to prevent trading on an uninformed basis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Provaris Energy Ltd (PV1) ORDINARY FULLY PAID |
Energy |
$9 |
Proposed issue of securities - PV1
|
22 Jun 2026 9:48AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
| Provaris Energy Ltd (PV1) ORDINARY FULLY PAID |
Energy |
$9 |
Capital Raising Completed to Support 2026 Program
|
22 Jun 2026 9:47AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
PV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- $1 million raised to support 2026 development program.
- Funds directed towards hydrogen and LCO2 projects.
- Approximately 130 million new shares issued at $0.0077 each.
- Free-attaching options provided with share purchase.
- Director participation pending shareholder approval.
- Settlement of shares scheduled for June 25, 2026.
- GBA Capital acted as sole lead manager.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$1,191 |
Change of Director's Interest Notice
|
22 Jun 2026 9:47AM |
$13.320 |
$12.220 |
fallen by
8.26%
|
|
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$29 |
Notice of change of interests of substantial holder
|
22 Jun 2026 9:45AM |
$0.105 |
$0.120 |
risen by
14.29%
|
|
| Zinc of Ireland Limited (ZMI) ORDINARY FULLY PAID |
Materials |
$24 |
Cleansing Notice
|
22 Jun 2026 9:42AM |
$0.015 |
$0.019 |
risen by
26.67%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,188 |
Ninth Supplementary Bidder's Statement
|
22 Jun 2026 9:42AM |
$5.100 |
$4.945 |
fallen by
3.04%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond Infraco 1 Pty Ltd makes an offer of A$5.10 per security for Atlas Arteria.
- The offer represents a significant premium to the previous trading prices of Atlas Arteria.
- The offer will close on 25 June 2026 unless the bidder's voting power increases to more than 50%, which would automatically extend the offer period.
- Securityholders are advised to accept the offer or risk exposure to various financial and operational risks associated with holding Atlas Arteria securities.
- The Ninth Supplementary Bidder's Statement was approved by Diamond Infraco 1 Pty Ltd directors and lodged with the Australian Securities and Investments Commission.
- IFM Global Infrastructure Fund, through Diamond Infraco, has increased its holding to over 40% of Atlas Arteria.
- The offer is unconditional, best and final, and is set at A$5.10 per security.
- There are risks of price decline if the offer is not accepted, as the pre-offer price was A$4.33.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,683 |
Distribution - year ending 30 June 2026
|
22 Jun 2026 9:42AM |
$4.750 |
$4.425 |
fallen by
6.84%
|
|
| Zinc of Ireland Limited (ZMI) ORDINARY FULLY PAID |
Materials |
$24 |
Application for quotation of securities - ZMI
|
22 Jun 2026 9:41AM |
$0.015 |
$0.019 |
risen by
26.67%
|
|
| Spenda Limited (SPX) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appointment / Resignation of Non-Executive Director
|
22 Jun 2026 9:40AM |
$0.003 |
$0.004 |
risen by
16.67%
|
|
| Centuria Capital Group (CNI) STAPLED SEC EXCL US INVESTOR PROHIBITED EXCL QPS |
Real Estate |
$1,492 |
Appendix 3B
|
22 Jun 2026 9:40AM |
$2.180 |
$1.490 |
fallen by
31.65%
|
|
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$5 |
Resignation / Appointment of Chairman
|
22 Jun 2026 9:39AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| Andromeda Metals Limited (ADN) ORDINARY FULLY PAID |
Materials |
$32 |
High Purity Alumina Project Update
|
22 Jun 2026 9:39AM |
$0.008 |
$0.007 |
fallen by
6.67%
|
|
ADN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commissioning of Andromeda’s HPA pilot plant is underway, with testwork to continue through Q3 2026.
- Commercial 4N HPA samples are targeted for customer qualification in the second half of 2026.
- The 2025 Scoping Study reported strong economics and low-cost production potential for the HPA project.
- There is potential upside from by-products, including silica and gallium.
- The proprietary process utilizes high-quality Great White kaolin feedstock from the Great White Project.
- Pilot plant testwork aims to produce HPA using a continuous process, transitioning from batch processing.
- The pilot plant will generate commercial samples and assess scalability for future feasibility studies.
- By-products generated during testwork, such as amorphous silica, have potential commercial applications.
- Gallium, considered a critical mineral, is present in the Great White kaolin feedstock and may represent an additional value pathway.
- The commissioning of the pilot plant marks a significant step in advancing Andromeda's HPA commercialisation strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Astron Corporation Limited (ATR) ORDINARY FULLY PAID |
Materials |
$204 |
Donald Project financing progress update
|
22 Jun 2026 9:39AM |
$0.555 |
$0.475 |
fallen by
14.41%
|
|
ATR - Price-sensitive ASX Announcement
Full Release
Key Points
- Astron Corporation Limited is focused on the Donald Rare Earths and Mineral Sands Project in Victoria, Australia.
- A non-binding Letter of Support from Export Finance Australia for A$80 million has been issued.
- A $220 million lending package is being pursued to fund Phase 1 of the project.
- Discussions for financing are ongoing with government agencies and commercial lenders.
- The final investment decision is expected in Q3 2026, pending financing finalization.
- The project is expected to produce rare earths for a vertically integrated supply chain with Energy Fuels Inc.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$10 |
Axel Validates Ionic REE ISR Development Pathway
|
22 Jun 2026 9:38AM |
$0.060 |
$0.056 |
fallen by
6.67%
|
|
AXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Axel REE Limited's column leach testwork program has shown promising results for in-situ recovery (ISR) at the Woolrich deposit.
- The column test CLT-01 recovered 560ppm soluble total rare earth oxides (TREO), exceeding previous diagnostic results.
- High-grade, magnet-rich rare earth recovery was achieved with very low impurity levels, supporting a low-impact, sustainable ISR development pathway.
- The results are generating operating data necessary for designing ISR field exploratory tests, marking a transition from laboratory to field-scale development.
- The testwork confirms Woolrich behaves as a genuine ionic-clay system, amenable to ISR conditions.
- Axel aims to position itself as a first-mover in commercial ISR rare earth extraction in the region.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mont Royal Resources Limited (MRZ) ORDINARY FULLY PAID |
Materials |
$19 |
Change of Director's Interest Notices
|
22 Jun 2026 9:36AM |
$0.140 |
$0.100 |
fallen by
28.57%
|
|
| HighCom Limited (HCL) ORDINARY FULLY PAID |
Industrials |
$16 |
FY26 Guidance Update
|
22 Jun 2026 9:36AM |
$0.145 |
$0.110 |
fallen by
24.14%
|
|
HCL - Price-sensitive ASX Announcement
Full Release
Key Points
- H2 FY26 revenue expected to be 70%-100% higher than H1 FY26 of $10.9 million
- EBITDA loss for H2 FY26 between $1.2 million and $1.6 million
- Revenue recognition timing and product mix changes affect guidance
- Certain armour orders deferred to FY27
- Stronger performance from the technology business offsets some variances
- Company maintains adequate cash position, no immediate need for capital raising
- Updated guidance reflects unaudited management accounts and expected contract completions by 30 June 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$57 |
EdenCrete - Strong Concrete Trial Results in India
|
22 Jun 2026 9:35AM |
$0.145 |
$0.090 |
fallen by
37.93%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- EdenCrete® trials in India show significant performance improvements.
- 28% reduction in abrasion for road mixes at low cost.
- 10-20% strength increase in high-strength mixes with cost reduction.
- Use of fly ash and slag reduces CO2 footprint and lowers costs.
- India's concrete market is rapidly growing due to government infrastructure spending.
- Successful trials with ready-mix companies, property developers, and CRRI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lightning Minerals Ltd (L1M) ORDINARY FULLY PAID |
Materials |
$6 |
L1M ADVANCES SECOND GOLD EXPLORATION PROGRAM AT MT TURNER
|
22 Jun 2026 9:35AM |
$0.017 |
$0.015 |
fallen by
11.76%
|
|
Call 1300 880 160
Start a chat
Schedule a call
